Bill & Melinda Gates Medical Research Institute
GPTKB entity
Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:affiliated_with |
gptkb:Bill_&_Melinda_Gates_Foundation
|
| gptkbp:aims_to |
improve health outcomes
foster innovation promote collaboration enhance research capacity strengthen health systems accelerate drug discovery develop vaccines improve vaccine delivery |
| gptkbp:collaborates_with |
academic institutions
pharmaceutical companies |
| gptkbp:engages_in |
clinical trials
|
| gptkbp:established |
gptkb:2017
|
| gptkbp:focuses_on |
disease prevention
global health |
| gptkbp:founded |
gptkb:Melinda_French_Gates
gptkb:Bill_Gates |
| gptkbp:has_impact_on |
gptkb:healthcare_access
global health policies disease control efforts |
| gptkbp:has_mission |
reduce health disparities
|
| gptkbp:has_part |
research teams
laboratory facilities collaborative networks |
| gptkbp:has_programs |
HIV research
maternal and child health vaccine development tuberculosis research malaria research |
| https://www.w3.org/2000/01/rdf-schema#label |
Bill & Melinda Gates Medical Research Institute
|
| gptkbp:is_involved_in |
community outreach
policy advocacy health education |
| gptkbp:is_supported_by |
government agencies
international organizations philanthropic contributions |
| gptkbp:location |
gptkb:Cambridge,_Massachusetts
|
| gptkbp:promotes |
public-private partnerships
|
| gptkbp:receives_funding_from |
gptkb:Bill_&_Melinda_Gates_Foundation
|
| gptkbp:research |
infectious diseases
non-communicable diseases |
| gptkbp:supports |
research projects
|
| gptkbp:type |
gptkb:non-profit_organization
|
| gptkbp:utilizes |
gptkb:Company
data analysis genomics |
| gptkbp:bfsParent |
gptkb:Bill_&_Melinda_Gates
|
| gptkbp:bfsLayer |
4
|